Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
World Journal of Urology|December 6, 2017
MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1Lei Chen, Hongwen Cao, Yigeng Feng
Fundamental & Clinical Pharmacology|May 8, 2018
Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signalLei Chen, Hongwen Cao, Chao Yu, et al.
Dose-Response : a Publication of International Hormesis Society|June 21, 2019
Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAXHongwen Cao, Yigeng Feng, Lei Chen, et al.
FEBS Open Bio|January 26, 2020
TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathwayHongwen Cao, Renjie Gao, Lei Chen, et al.
Complementary Medicine Research|June 2, 2021
Qi Ling Inhibits Progression of Androgen-Independent Prostate Cancer via Negative Regulation of TRIM66/HP1γ/AR AxisYigeng Feng, Dongwen Gao, Hongwen Cao, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2017
Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axisHongwen Cao, Hongjie Yu, Yigeng Feng, et al.
Journal of Ovarian Research|May 10, 2022
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosisYaxian Liu, Hongwen Cao, Yanhui Zhao, et al.
Pageof 4